NAD+

Featured

Also known as: Nicotinamide Adenine Dinucleotide, NAD, Coenzyme

An essential coenzyme for cellular energy and longevity pathways.

Overview

NAD+ (Nicotinamide Adenine Dinucleotide) is a critical coenzyme found in all living cells. It plays essential roles in energy metabolism, DNA repair, and sirtuin activation. NAD+ levels decline with age, and supplementation or IV infusion is being researched for anti-aging, neuroprotection, and addiction treatment.

Mechanism of Action

Functions as electron carrier in redox reactions for ATP production. Required for sirtuin activity (SIRT1-7) which regulate aging processes. Essential for PARP-mediated DNA repair. Declines significantly with age.

Pharmacokinetics

IV infusion provides direct NAD+ delivery. Oral precursors (NMN, NR) are also used. Half-life of circulating NAD+ is short; cellular pools are regulated.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

IV Infusion

Dose

250-500 mg

Frequency

1-4x weekly

Duration

Series of 4-10

Infuse over 2-4 hours to reduce side effects

2

High Dose IV

Dose

750-1000 mg

Frequency

Weekly

Duration

4-8 sessions

For addiction or severe fatigue

3

Oral NMN/NR

Dose

250-1000 mg

Frequency

Daily

Duration

Ongoing

NAD+ precursor supplements

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Longevity synergy

Synergy: Multiple anti-aging pathways

Rationale: Mitochondrial support

Synergy: Enhanced cellular energy

Research Areas

AgingLongevityNeuroprotectionAddiction TreatmentChronic FatigueMitochondrial FunctionDNA Repair

Key Research Findings

  • 1NAD+ levels decline 50%+ with age
  • 2Sirtuin activation requires NAD+
  • 3IV infusion used for addiction and fatigue
  • 4Precursors (NMN, NR) can raise NAD+ levels

Side Effects & Contraindications

Reported Side Effects

  • Flushing (IV)
  • Nausea
  • Chest tightness (IV)
  • Headache
  • Fatigue during infusion

Contraindications

  • Active cancer (theoretical concern)
  • Severe cardiovascular disease (for IV)

Safety Considerations

IV infusion can cause flushing, nausea, chest tightness during administration. Start slow. Generally safe but expensive. Oral precursors are alternative.

Storage Requirements

Refrigerate solutions, protect from light

Scientific References

Quick Reference

Sequence
N/A - Coenzyme
Molecular Weight
663.4 g/mol
Half-Life
Variable (hours in circulation)
Bioavailability
IV 100%, oral precursors variable
Research Stage
clinical phase 2
Administration
IV infusion or oral precursors